Skip to main content

Closed

CNSP: CNS Pharmaceuticals, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-5485.5%

Financially safe

Stretched

Debt / equity3.29×

Interest coverage-1098.5×

Current ratio0.88×

CNS Pharmaceuticals, Inc.

CNSPNASDAQ Capital Market·USD·Closed

CNS Pharmaceuticals, Inc.

CNSPNASDAQ·USD·Closed

$5.82

+19.94%

$5.82

+$0.97 (19.94%)

52W Range

45thpctl

Volume

0.01×avg

Mkt Cap

3.34MUSD

P/E

-0.2TTM

Div Yield

–ann

52W Range

45thpctl

Volume

0.01×avg

Market Cap

3.34MUSD

P/E Ratio

-0.2TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings